- Home
- AMLX vs OCSL Comparison
AMLX vs OCSL Comparison
Compare AMLX & OCSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AMLX | OCSL |
|---|---|---|
| Founded | 2014 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | 2022 | 2008 |
Fundamental Metrics
Financial Performance| Metric | AMLX | OCSL |
|---|---|---|
| Price | $12.33 | $12.79 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 3 |
| Target Price | ★ $17.43 | $14.33 |
| AVG Volume (30 Days) | ★ 1.4M | 828.4K |
| Earning Date | 11-06-2025 | 02-03-2026 |
| Dividend Yield | N/A | ★ 12.60% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.39 |
| Revenue | N/A | ★ $316,801,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $0.38 |
| P/E Ratio | ★ N/A | $32.23 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.60 | $12.44 |
| 52 Week High | $16.96 | $16.29 |
Technical Indicators
Market Signals| Indicator | AMLX | OCSL |
|---|---|---|
| Relative Strength Index (RSI) | 40.94 | 35.88 |
| Support Level | $11.69 | $12.61 |
| Resistance Level | $12.80 | $12.99 |
| Average True Range (ATR) | 0.67 | 0.20 |
| MACD | -0.08 | -0.07 |
| Stochastic Oscillator | 21.53 | 14.67 |
Price Performance
Historical ComparisonAbout AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.
About OCSL Oaktree Specialty Lending Corporation
Oaktree Specialty Lending Corp is a specialty finance company. The company provides lending services and invests in small and mid-sized companies. The company's investment objective is to maximize its portfolio's total return by generating current income from debt investments, and to a lesser extent, capital appreciation from equity investments. The company provides customized, one-stop credit solutions to companies with limited access to public or syndicated capital markets.